OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GZ0G9A3

Real-time BOERSE MUENCHEN 03:55:44 22/05/2024 pm IST
12.4 EUR +0.32% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO.
Current month-1.90%
1 month-2.29%
Date Price Change
22/24/22 12.4 +0.32%
21/24/21 12.36 +1.15%
20/24/20 12.22 -0.33%
17/24/17 12.26 +0.74%
16/24/16 12.17 +0.41%

Real-time BOERSE MUENCHEN

Last update May 22, 2024 at 03:55 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0G9A
ISINDE000GZ0G9A3
Date issued 21/09/2022
Strike 369.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 12.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.66
Lowest since issue 7.32
Spread 0.1
Spread %0.80%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW